FDA, EU Review Sanofi Heart Drug After Failed Trial
American and European regulators said Thursday that they were reviewing the safety of Sanofi-Aventis SA's heart drug Multaq after the company halted a clinical trial in which users of Multaq were...To view the full article, register now.
Already a subscriber? Click here to view full article